A UK man likely set a new narcotics world record after he consumed 40,000 ecstasy tablets over nearly a decade and lived to tell the tale. The extreme drug binge was originally documented in 2006, but ...
The psychiatrist used to have to stay with the patient during their entire session. Now they’ll be able to leave the room ...
Clin Nurse Spec. 2005;19(2):63-64. In my pediatric practice, increasingly I am hearing about adolescent use of Ecstasy. Patients report that the drug is not addictive and is prevalent at parties. What ...
The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy," to support psychotherapy for mental illnesses such as post-traumatic stress disorder is ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...
Some call the drug "ecstasy" or "molly." Researchers are calling it a potential tool to help treat loneliness. As public health experts sound the alarm on a rising loneliness epidemic in the United ...
A new study is adding to evidence that the party drug "ecstasy" can boost the benefits of talk therapy for people suffering from post-traumatic stress disorder (PTSD). In a clinical trial, researchers ...
Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. There’s ...
The drug 3,4-Methylenedioxymethamphetamine (MDMA), also known as 'ecstasy', seems to produce dose-related increases in myocardial oxygen demand without an increase in the contractility of the heart.
NEW YORK, Nov. 17 (UPI) --The Food and Drug Administration soon may approve the recreational psychedelic drug MDMA -- alongside supportive therapy -- to treat post-traumatic stress disorder after two ...